Brought to you by 
Novartis to market Grifols' immunohematology products in the US
05 Apr 2011
Executive Summary
Novartis Molecular Diagnostics has agreed to market and distribute in the US Grifols SA’s immunohematology instruments, assays, and other diagnostic products upon approval.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com